FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancer.

Sci Adv · 2026 · PMC13292942 · PMID 42341116

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Notably, [ 89 Zr]Zr-DFO-αFOLR1 demonstrated an increasing trend in tumor accumulation and remained in circulation at 72 hours p.i.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.